Omnicell, Inc. (OMCL) Q2 2025 Earnings Conference Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Kathleen Nemeth - Senior Vice President of Investor Relations Nchacha E. Etta - Executive VP & CFO Randall A.
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
The mean of analysts' price targets for Omnicell (OMCL) points to a 44.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.51 per share a year ago.
OMCL vs. DOCS: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Omnicell (OMCL) and Doximity (DOCS). But which of these two stocks offers value investors a better bang for their buck right now?
Analysts Estimate Omnicell (OMCL) to Report a Decline in Earnings: What to Look Out for
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.
Omnicell (OMCL) Up 27% Since Last Earnings Report: Can It Continue?
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Omnicell's New Perioperative Clinic Setting Products May Boost Stock
OMCL unveils new offerings for the perioperative and clinic setting.
Omnicell: Facing New Headwinds
Omnicell, Inc., a small cap medical technology solutions provider, posted its Q1 results Tuesday. Both top and the bottom-line results beat the consensus. However, thanks to some new headlines and reduced forward guidance, OMCL shares sold off 15% in trading yesterday. A buying opportunity? An analysis around Omnicell follows in the paragraphs below.
Omnicell Q1 Earnings & Revenues Beat, '25 EPS View Down, Stock Up
OMCL posts better-than-expected top and bottom-line results for the first quarter of 2025.
Omnicell, Inc. (OMCL) Q1 2025 Earnings Conference Call Transcript
Omnicell, Inc. (NASDAQ:OMCL ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Kathleen Nemeth - SVP, IR Randall Lipps - Founder, Chairman, President and CEO Nchacha Etta - EVP and CFO Nnamdi Njoku - COO Conference Call Participants Jessica Datson - Piper Sandler Gene Mannheimer - Freedom Capital Markets Allen Lutz - Bank of America Bill Sutherland - Benchmark Stan Berenshteyn - Wells Fargo Matt Hewitt - Craig-Hallum Capital David Larsen - BTIG Operator Good morning, my name is Carly and I will be your conference operator today. At this time, I would like to welcome everyone to the Omnicell First Quarter 2025 Financial Results Conference Call.
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago.
